Cardio Diagnostics, Inc, a biotechnology company making cardiovascular disease prevention and early detection more accessible, personalized and precise, announces the launch of its patent-pending ...

CHICAGO--(BUSINESS WIRE)-- Cardio Diagnostics Holdings Inc (Nasdaq: CDIO), an artificial intelligence-powered precision cardiovascular medicine company, today announced the launch of PrecisionCHD™, an ...

AI-enabled cardiovascular company Cardio Diagnostics Holdings announced it is partnering with care-navigation platform Navierre to make assessing risk and diagnosing heart diseases more accessible.

Cardio Diagnostics (NASDAQ: CDIO), an artificial intelligence-powered precision cardiovascular medicine company that makes cardiovascular disease prevention and early detection more precise, has ...

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), a leader in epigenetics and AI-driven Precision Cardiovascular Medicine, Aimil Ltd., a company at the forefront of the ...

Fitness alone doesn’t guarantee heart health. Cardiologists explain lesser-known tests like hs-CRP, lipoprotein(a), calcium ...

CHICAGO - Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) has announced the publication of a study indicating its PrecisionCHD™ test could significantly reduce healthcare costs for coronary heart ...

CHICAGO, Oct. 25, 2023 /PRNewswire/ -- The cardiac marker testing industry is poised for significant advancements in the near future, driven by breakthroughs in diagnostic technologies and an ...

Pune, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Cardiac Biomarker Testing Market Size & Growth Analysis: “According to SNS Insider, The Cardiac Biomarker Testing Market size was valued at USD 4.53 billion in ...

Dublin, Aug. 15, 2022 (GLOBE NEWSWIRE) -- The "Cardiac POC Testing Devices - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Cardiac POC ...